Mesoblast Limited (MESO) Social Stream



Mesoblast Limited (MESO): $3.55

-0.04 (-1.11%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

F

Add MESO to Watchlist
Sign Up

Industry: Medical - Pharmaceuticals

Industry

D

Ranked

#136 of 168

in industry

MESOBLAST LTD (MESO) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering MESO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-24 6 $23 $6.5 $15.9 $3.63 338.02%
2022-02-28 4 $23 $6.5 $15.9 $3.63 338.02%
2022-04-08 5 $23 $6.5 $14.3 $3.63 293.94%
2022-04-29 5 $23 $6.5 $13.5 $3.63 271.9%
2022-06-01 6 $23 $6.5 $13.5 $3.63 271.9%
2022-06-06 6 $23 $2.5 $12.7 $3.63 249.86%
2022-08-31 6 $23 $2.5 $12.875 $3.63 254.68%
2022-09-06 7 $23 $2.5 $11.7 $3.63 222.31%
2022-11-23 6 $23 $2.5 $11.7 $3.63 222.31%
2023-03-01 5 $23 $2.5 $10.625 $3.63 192.7%
2023-04-30 6 $23 $2.5 $10.1 $3.63 178.24%
2023-05-26 6 $23 $2.5 $10.625 $3.63 192.7%
2023-05-30 6 $23 $2 $10.5 $3.63 189.26%

The Trend in the Analyst Price Target


MESO's average price target has moved down $3 over the prior 52 weeks.

Over the past 51 weeks, MESO's average upside potential has been 248.95%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-09-06 6 23 2.5 11.700 2.87 307.67%
2023-02-01 5 23 2.5 10.625 3.59 195.96%
2023-02-08 5 23 2.5 10.625 4.18 154.19%
2023-03-09 6 23 2.5 10.100 3.50 188.57%
2023-04-30 6 23 2.5 10.100 2.95 242.37%

MESO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 5 0 0 1 1 6

The Trend in the Broker Recommendations


MESO's average broker recommendation rating improved by 0.13 over the prior 43 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MESO as an investment opportunity.

  • In the context of all US stocks, MESOBLAST LTD's variance in analysts' estimates is lower than -1222.07% of them.
  • MESO has a greater upside potential (average analyst target price relative to current price) than 1227.16% of all US stocks.
  • MESO has a higher average analyst price target than 209.13% of stocks in the mid market cap category.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, MESOBLAST LTD's number of analysts covering the stock is greater than 423.58% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to MESOBLAST LTD are ALVR, KYMR, and BCAB.

Is MESO a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6558 seconds.